News & Events CTI CEO to Present at American Society of Nephrology Kidney Week

CTI CEO to Present at American Society of Nephrology Kidney Week

October 23, 2018

CTI Clinical Trial and Consulting Services (CTI), a multi-national, privately held, full-service contract research organization, will present at the American Society of Nephrology's (ASN) annual Kidney Week. Kidney Week, the world's premier nephrology meeting, will be held October 23-28 in San Diego, CA.

Timothy Schroeder, CEO and Founder of CTI, will give a presentation titled "All About e-Trials: Nuts (Bytes) and Bolts (Scans)," on October 25 at 3pm in the San Diego Convention Center in room 26A. The presentation will be part of a special session titled, "Innovating for Kidney Diseases: From Cells to Clinical Trials." The session, consisting of four separate presentations including Schroeder's, will explore the sequential process that could change the way nephrology professionals address kidney diseases, both in the context of discovery and process of care.

"I am looking forward to being a part of this session exploring the future of kidney diseases," remarks Schroeder. "CTI is a recognized leader in nephrology, and we have seen many groundbreaking advances in the field over the past 20 years. We are honored to continue to be a part of the conversations that generate new ideas and further advances in therapies and treatments for chronically and critically-ill patients."

Timothy Schroeder has more than 35 years of clinical, academic, and industry experience in global drug and device development programs. CTI, founded in 1999, is a multi-national research firm with associates in North America, Europe, Latin America and Asia-Pacific. The firm, which in one of the 20 largest CROs in the world and has supported more than 100 drug and device approvals, currently works on behalf of approximately 120 global pharmaceutical and biotechnology companies. Prior to founding CTI, Tim held numerous faculty positions with the University of Cincinnati College of Medicine. He was also the founding Executive Vice President of Clinical Development at SangStat Medical Corporation, which went public in 1995. Tim is currently a board member for over a dozen corporate and non-profit organizations, including Xavier University, which he attended. Tim was named as an EY Entrepreneur of the Year in 2015, as Top Leader by the Enquirer Media in 2016, and as Deal Maker of the Year in 2017 by the Association for Corporate Growth.

Subscribe to our mailing list

* indicates required